On February 2, 2021, HELIX IMMUNO-ONCOLOGY S.A. submitted the following documents to the Financial Document Repository for the fiscal year running from August 1, 2019 to July 31, 2020:
- Financial statement,
-
Managing Board report on Company business activities,
-
Auditor’s opinion / report on the audit of the annual financial statement
-
Resolution on allocation of profit,
-
Resolution on approval of the annual financial statement.